Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sober Grid was a private digital health and behavioral healthcare company focused on substance use disorder recovery support. Its core product was a mobile app that connected people in recovery through a geolocation-based sober social network, community features, urgent peer-support tools, and paid certified peer coaching. The company positioned its offering as a chronic disease management platform for addiction, covering alcohol, opioid, cocaine, and other substance dependencies. Sober Grid also highlighted AI-enabled relapse-risk prediction and worked with academic collaborators including Harvard Medical School and the University of Pennsylvania Perelman School of Medicine. Although the business had operated commercially and received NIH/NSF-backed support, available sources indicate the company and app are no longer operational as of 2025-2026.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sober Grid.